S. Yoshida

发表

High glucose induces N-linked glycosylation-mediated functional upregulation and overexpression of Cav3.2 T-type calcium channels in neuroendocrine-like differentiated human prostate cancer cells.

A. Kawabata, Kazuki Fukami, Erina Asano, 2017, Journal of pharmacological sciences.

Novel GPR40 agonist AS2575959 exhibits glucose metabolism improvement and synergistic effect with sitagliptin on insulin and incretin secretion.

T. Shimokawa, K. Negoro, S. Yoshida, 2014, Life sciences.

Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion

K. Negoro, S. Yoshida, H. Tanaka, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Synthesis and structure-activity relationship of 4-amino-2-phenylpyrimidine derivatives as a series of novel GPR119 agonists.

K. Negoro, M. Takeuchi, S. Yoshida, 2012, Bioorganic & medicinal chemistry.

Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor.

H. Matsushime, K. Momose, H. Hiyama, 2005, Biochemical and biophysical research communications.

Comparison of intravenous nutrients on gut mucosal proteins synthesis.

T. Stein, S. Yoshida, M. Schluter, 1994, JPEN. Journal of parenteral and enteral nutrition.

New nomenclature for the human tissue kallikrein gene family.

P. Nelson, J. Clements, L. Ashworth, 2000, Clinical chemistry.

Muscle Develops a Specific Form of Small Heat Shock Protein Complex Composed of MKBP/HSPB2 and HSPB3 during Myogenic Differentiation*

M. Waye, S. Tsui, S. Yoshida, 2000, The Journal of Biological Chemistry.

Eicosapentaenoic acid inhibits cholesteryl ester accumulation in rat peritoneal macrophages by decreasing the number of specific binding sites of acetyl LDL.

Y. Tamura, S. Yoshida, I. Saito, 1992, Clinical biochemistry.

Crystal Structure of Neuropsin, a Hippocampal Protease Involved in Kindling Epileptogenesis*

K. Matsumoto, T. Kishi, Masato Kato, 1999, The Journal of Biological Chemistry.

Improvement of Mitochondrial Function and Lipid Utilization by 3,5-dihydroxy-4-methoxybenzyl Alcohol, an Oyster-derived polyphenol, in Oleate-loaded C2C12 Myotubes

H. Chiba, N. Kawanishi, S. Yoshida, 2016 .

Involvement of Src kinase in T‐type calcium channel‐dependent neuronal differentiation of NG108‐15 cells by hydrogen sulfide

A. Kawabata, Kazuki Fukami, F. Sekiguchi, 2010, Journal of neurochemistry.

The organic mercury compounds, methylmercury and ethylmercury, inhibited ciliary movement of ventricular ependymal cells in the mouse brain around the concentrations reported for human poisoning.

T. Minami, S. Yoshida, T. Hagiwara, 2016, Neurotoxicology.

The role of small molecule GPR119 agonist, AS1535907, in glucose‐stimulated insulin secretion and pancreatic β‐cell function

S. Yoshida, M. Shibasaki, H. Oshima, 2011, Diabetes, obesity & metabolism.

Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice.

S. Yoshida, H. Tanaka, M. Shibasaki, 2010, Biochemical and biophysical research communications.

Inhibitory effect of prostaglandin E2 on cholesterol ester accumulation in macrophages.

M. Kitahara, N. Morisaki, S. Yoshida, 1986, Biochemical and biophysical research communications.

Up‐regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator‐activated receptor ligands and 9‐cis retinoic acid in L6 myotubes

M. Saito, S. Yoshida, X. Cañas, 1999, FEBS letters.

Enhancement of serotonin- and bradykinin-evoked calcium ion dynamics in differentiated NG108-15 cells

T. Wada, S. Ichida, S. Yoshida, 2006, Neuroscience Letters.

Metabolism of acetylated low density lipoproteins by monocyte-derived macrophages from patients with Werner's syndrome.

N. Morisaki, S. Yoshida, Y. Saito, 1989, Arteriosclerosis.

Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion.

S. Yoshida, M. Shibasaki, T. Matsui, 2010, Biochemical and biophysical research communications.

Oxidized Low-density Lipoprotein Upregulates GM2 Activator Protein Gene Expression

S. Yoshida, H. Yanai, H. Yoshida, 2005 .

Characteristics for Enhanced Response of Serotonin-Evoked Ion Dynamics in Differentiated NG108-15 Cells

T. Masuko, Hajime Asano, Y. Funakami, 2009, Neurochemical Research.

Inhibition of T-type calcium channels and hydrogen sulfide-forming enzyme reverses paclitaxel-evoked neuropathic hyperalgesia in rats

A. Kawabata, F. Sekiguchi, S. Yoshida, 2011, Neuroscience.

Developmental expression of a novel Kexin family protease, PACE4E, in the rat olfactory system

H. Nagamune, A. Tsuji, S. Daikoku, 1997, Histochemistry and Cell Biology.

Hydrogen sulfide as a novel nociceptive messenger

Y. Maeda, T. Wada, S. Ichida, 2007, Pain.

Gene expression of the concentration-sensitive sodium channel is suppressed in lipopolysaccharide-induced acute lung injury in mice

S. Yoshida, T. Hagiwara, Y. Hidaka, 2017, Experimental lung research.

Discovery and biological evaluation of novel 4-amino-2-phenylpyrimidine derivatives as potent and orally active GPR119 agonists.

K. Negoro, M. Takeuchi, S. Yoshida, 2012, Bioorganic & medicinal chemistry.

Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells.

A. Kawabata, Kazuki Fukami, Erina Asano, 2015, Biochemical pharmacology.

Protein Kinase C-dependent, CCAAT/Enhancer-binding Protein β-mediated Expression of Insulin-like Growth Factor I Gene*

M. Hori, Y. Yamasaki, T. Yasuda, 2002, The Journal of Biological Chemistry.

The therapeutic potential of GPR119 agonists for type 2 diabetes

S. Yoshida, Shigeru Yoshida, Takahide Ohishi, 2012, Expert opinion on investigational drugs.

Increased Response to High KCl-Induced Elevation in the Intracellular-Ca2+ Concentration in Differentiated NG108-15 Cell and the Inhibitory Effect of the L-Type Ca2+ Channel Blocker, Calciseptine

T. Wada, S. Ichida, S. Yoshida, 2005, Neurochemical Research.

Blockade of T-type calcium channels by 6-prenylnaringenin, a hop component, alleviates neuropathic and visceral pain in mice

Mio Ichikawa, A. Kawabata, F. Sekiguchi, 2018, Neuropharmacology.

Discovery of pimozide derivatives as novel T-type calcium channel inhibitors with little binding affinity to dopamine D2 receptors for treatment of somatic and visceral pain.

A. Kawabata, F. Sekiguchi, S. Yoshida, 2022, European journal of medicinal chemistry.

Critical role of Cav3.2 T-type calcium channels in the peripheral neuropathy induced by bortezomib, a proteasome-inhibiting chemotherapeutic agent, in mice.

Takaya Miyazaki, A. Kawabata, F. Sekiguchi, 2019, Toxicology.

Design and synthesis of novel anti-hyperalgesic agents based on 6-prenylnaringenin as the T-type calcium channel blockers.

A. Kawabata, F. Sekiguchi, S. Yoshida, 2018, Bioorganic & medicinal chemistry.

Therapeutic potential of RQ-00311651, a novel T-type Ca2+ channel blocker, in distinct rodent models for neuropathic and visceral pain

A. Kawabata, F. Sekiguchi, S. Yoshida, 2016, Pain.

Endogenous and exogenous hydrogen sulfide facilitates T-type calcium channel currents in Cav3.2-expressing HEK293 cells.

A. Kawabata, F. Sekiguchi, S. Yoshida, 2014, Biochemical and biophysical research communications.

AKAP‐dependent sensitization of Cav3.2 channels via the EP4 receptor/cAMP pathway mediates PGE2‐induced mechanical hyperalgesia

A. Kawabata, F. Sekiguchi, S. Yoshida, 2013, British journal of pharmacology.

Hydrogen sulfide evokes neurite outgrowth and expression of high‐voltage‐activated Ca2+ currents in NG108‐15 cells: involvement of T‐type Ca2+ channels

S. Ichida, A. Kawabata, Kazuki Fukami, 2009, Journal of neurochemistry.

Enhancement of Sodium Current in NG108-15 Cells during Neural Differentiation is Mainly due to an Increase in NaV1.7 Expression

Hajime Asano, T. Wada, S. Ichida, 2007, Neurochemical Research.

A hydrolysate of poly-trans-[(2-carboxyethyl)germasesquioxane] (Ge-132) suppresses Cav3.2-dependent pain by sequestering exogenous and endogenous sulfide

A. Kawabata, F. Sekiguchi, S. Yoshida, 2022, Redox Biology.

Genetic deletion of Cav3.2 T-type calcium channels abolishes H2S-dependent somatic and visceral pain signaling in C57BL/6 mice.

K. Matsui, H. Masuda, Takaya Miyazaki, 2019, Journal of pharmacological sciences.

Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle

Takahiro Iwamoto, Issei Komuro, I. Komuro, 2004, Nature Medicine.

Contribution of concentration-sensitive sodium channels to the absorption of alveolar fluid in mice

S. Yoshida, T. Hagiwara, Teruki Hagiwara, 2016, Respiratory Physiology & Neurobiology.

Crystallization and preliminary X-ray analysis of neuropsin, a serine protease expressed in the limbic system of mouse brain.

K. Matsumoto, T. Kishi, T. Hakoshima, 1997, Journal of structural biology.

Sodium transport through the cerebral sodium–glucose transporter exacerbates neuron damage during cerebral ischaemia

T. Wada, S. Yoshida, S. Tokuyama, 2016, The Journal of pharmacy and pharmacology.

Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.

S. Yoshida, A. Shimaya, M. Shibasaki, 2006, Biochemical pharmacology.

Poly(ADP-ribose) polymerase stimulates DNA polymerase alpha by physical association.

Y. Shizuta, K. Kojima, S. Izuta, 1993, The Journal of biological chemistry.

Down‐regulation of immediate early gene egr‐1 expression in rat C6 glioma cells by short‐term exposure to high salt culture medium

H. Arimochi, K. Morita, S. Yoshida, 2005, Cell biology international.

AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes.

S. Yoshida, H. Tanaka, M. Shibasaki, 2010, Biochemical and biophysical research communications.

Novel GPR119 agonist AS1669058 potentiates insulin secretion from rat islets and has potent anti-diabetic effects in ICR and diabetic db/db mice.

Y. Uchiyama, S. Yoshida, H. Tanaka, 2013, Life sciences.

Genomic organization and alternative splicing of human PACE4 (SPC4), kexin-like processing endoprotease.

A. Tsuji, S. Yoshida, T. Akamatsu, 1997, Journal of biochemistry.

Human subtilisin-like proprotein convertase, PACE4 (SPC4) gene expression is highly regulated through E-box elements in HepG2 and GH4C1 cells.

K. Mori, A. Tsuji, S. Yoshida, 1999, Journal of biochemistry.

Enhancement of veratridine-induced sodium dynamics in NG108-15 cells during differentiation.

T. Masuko, T. Wada, S. Ichida, 2006, Biological & pharmaceutical bulletin.

Sodium influx through cerebral sodium‐glucose transporter type 1 exacerbates the development of cerebral ischemic neuronal damage

T. Wada, S. Yoshida, S. Tokuyama, 2017, European journal of pharmacology.

Differential effects of YM440 a hypoglycemic agent on binding to a peroxisome proliferator-activated receptor gamma and its transactivation.

S. Yoshida, A. Shimaya, M. Shibasaki, 2003, Biochemical pharmacology.

Opioid modulation of T-type Ca2+ channel-dependent neuritogenesis/neurite outgrowth through the prostaglandin E2/EP4 receptor/protein kinase A pathway in mouse dorsal root ganglion neurons.

A. Kawabata, F. Sekiguchi, S. Yoshida, 2023, Biochemical and Biophysical Research Communications - BBRC.

Luminal hydrogen sulfide plays a pronociceptive role in mouse colon

S. Yoshida, A. Kawabata, S. Yoshida, 2008, Gut.

The prostaglandin E2/EP4 receptor/cyclic AMP/T-type Ca(2+) channel pathway mediates neuritogenesis in sensory neuron-like ND7/23 cells.

A. Kawabata, F. Sekiguchi, S. Yoshida, 2016, Journal of pharmacological sciences.

Synthesis and structure-activity relationship of fused-pyrimidine derivatives as a series of novel GPR119 agonists.

K. Negoro, Kazuhiko Iikubo, M. Takeuchi, 2012, Bioorganic & medicinal chemistry.

The organic mercury compounds, methylmercury and ethylmercury, inhibited ciliary movement of ventricular ependymal cells in the mouse brain around the concentrations reported for human poisoning.

T. Minami, S. Yoshida, Shinsaku Matsumoto, 2016, Neurotoxicology.

Estrogen and bisphenol A disrupt spontaneous [Ca(2+)](i) oscillations in mouse oocytes.

S. Yoshida, T. Mohri, 2004, Biochemical and biophysical research communications.

Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells.

A. Kawabata, Kazuki Fukami, Erina Asano, 2015, Biochemical pharmacology.